Cells constantly monitor and remove faulty mitochondrial RNA to protect energy production. Mitochondrial genomes produce long polycistronic transcripts that must be processed, modified, and translated within the organelle. When RNA molecules are misprocessed, chemically damaged, or form aberrant structures they can stall ribosomes or expose unusual ends that mark them for quality control. Researchers including Nils-Göran Larsson Karolinska Institute and Eric A. Shoubridge McGill University have characterized pathways linking RNA stability to mitochondrial function and human disease.
How damaged mtRNA is recognized
Recognition depends on the interplay between translation, RNA-binding proteins, and ribonucleases. Stalled mitochondrial ribosomes act as sensors: when translation cannot proceed because of a damaged message, associated factors and exposed RNA ends recruit surveillance machinery. Aberrant polyadenylation or loss of protective RNA-binding proteins such as LRPPRC makes transcripts more susceptible to decay. Subtle changes in RNA secondary structure or chemical lesions from oxidative stress are often sufficient to shift a transcript from a functional state to a target for clearance.
Clearance mechanisms and consequences
Degradation is primarily executed by a mitochondrial RNA helicase and exoribonuclease complex known as the mitochondrial degradosome, composed of SUPV3L1 and PNPT1. The helicase unwinds structured RNAs while the exoribonuclease degrades them from exposed ends, preventing accumulation of defective RNAs that would otherwise interfere with translation and assembly of respiratory complexes. Additional nucleases and processing enzymes including mitochondrial RNase Z and RNase P processes contribute to trimming and turnover. Failure of these systems leads to accumulation of aberrant RNAs, defective translation, and respiratory chain dysfunction, which manifests most severely in high-energy tissues such as brain and muscle. Mutations in stabilization factors have clinical consequences; for example dysfunction of LRPPRC is linked to a form of Leigh syndrome observed in certain French Canadian populations, illustrating how genetic and territorial factors intersect with mitochondrial RNA biology.
Maintaining mitochondrial RNA integrity therefore safeguards cellular bioenergetics and organismal health. Ongoing studies by mitochondrial biologists continue to refine how surveillance distinguishes transient errors from irreparable damage and how modulation of these pathways might mitigate mitochondrial disease.